InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Stian Kildal, 首席执行官. Director active across 1 company, notably OncoZenge AB. In total, 4 disclosures have been logged. Activity tracked since 28 March 2025. The latest transaction was disclosed on 6 September 2026 (Purchase). Regulator: FIN-FSA. All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Stian Kildal is the CEO of OncoZenge AB. He is responsible for the strategic direction and daily management of the company. With experience in the biotechnology field, Stian strives to promote innovation and growth within OncoZenge AB.